{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:35:53Z","timestamp":1767832553244,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.ajog.2009.07.040","type":"journal-article","created":{"date-parts":[[2009,10,5]],"date-time":"2009-10-05T11:52:52Z","timestamp":1254743572000},"page":"68.e1-68.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Increased SLIT immunoreactivity as a biomarker for recurrence in endometrial carcinoma"],"prefix":"10.1016","volume":"202","author":[{"given":"Shulan","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xishi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Guo","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2009.07.040_bib1","first-page":"74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2009.07.040_bib2","first-page":"11","article-title":"Cancer incidence trends in urban Shanghai, 1972-1999 [Chinese]","volume":"24","author":"Liu","year":"2004","journal-title":"Tumor"},{"key":"10.1016\/j.ajog.2009.07.040_bib3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","article-title":"Endometrial cancer","volume":"366","author":"Amant","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2009.07.040_bib4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2006.02.011","article-title":"Follow-up after primary therapy for endometrial cancer: a systematic review","volume":"101","author":"Fung-Kee-Fung","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2009.07.040_bib5","first-page":"461","article-title":"Endometrial carcinoma: is routine intensive periodic follow-up of value?","volume":"21","author":"Menczer","year":"2000","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ajog.2009.07.040_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1996.0022","article-title":"Endometrial carcinoma\u2013relative effectiveness of adjuvant irradiation vs therapy reserved for relapse","volume":"60","author":"Ackerman","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2009.07.040_bib7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/AOG.0b013e318162f690","article-title":"Endometrial cancer","volume":"111","author":"Sorosky","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2009.07.040_bib8","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/cncr.2820710411","article-title":"Prognostic significance of hormone receptors in endometrial cancer","volume":"71","author":"Creasman","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2009.07.040_bib9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/ijgc-00009577-200205000-00008","article-title":"Immunohistochemical evaluation is not prognostic for recurrence in fully staged high-risk endometrial cancer","volume":"12","author":"Fanning","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2009.07.040_bib10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2005.08.001","article-title":"Steroid receptor expressions in endometrial cancer: clinical significance and epidemiological implication","volume":"239","author":"Jeon","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajog.2009.07.040_bib11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10147-008-0825-8","article-title":"Novel therapeutic strategy for uterine endometrial cancers","volume":"13","author":"Fujimoto","year":"2008","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ajog.2009.07.040_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2009.07.040_bib13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.ajog.2009.07.040_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2005.09.005","article-title":"Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors","volume":"8","author":"Casanovas","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajog.2009.07.040_bib15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0092-8674(00)80590-5","article-title":"Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance","volume":"96","author":"Brose","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.ajog.2009.07.040_bib16","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0092-8674(00)80588-7","article-title":"Biochemical purification of a mammalian slit protein as a positive regulator of sensory axon elongation and branching","volume":"96","author":"Wang","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.ajog.2009.07.040_bib17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/22477","article-title":"Directional guidance of neuronal migration in the olfactory system by the protein Slit","volume":"400","author":"Wu","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2009.07.040_bib18","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/35073616","article-title":"The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors","volume":"410","author":"Wu","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2009.07.040_bib19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0959-437X(02)00343-X","article-title":"Slit proteins: molecular guidance cues for cells ranging from neurons to leukocytes","volume":"12","author":"Wong","year":"2002","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.ajog.2009.07.040_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1535-6108(03)00164-8","article-title":"Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity","volume":"4","author":"Wang","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajog.2009.07.040_bib21","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1073\/pnas.0408318102","article-title":"Roundabout4 is essential for angiogenesis in vivo","volume":"102","author":"Bedell","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajog.2009.07.040_bib22","doi-asserted-by":"crossref","first-page":"11347","DOI":"10.1074\/jbc.M508853200","article-title":"Robo4 signaling in endothelial cells implies attraction guidance mechanisms","volume":"281","author":"Kaur","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajog.2009.07.040_bib23","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1349-7006.2007.00721.x","article-title":"Targeting Slit-Roundabout signaling inhibits tumor angiogenesis in chemical-induced squamous cell carcinogenesis","volume":"99","author":"Wang","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ajog.2009.07.040_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/00313020802197897","article-title":"Calretinin and CD34 immunoreactivity of the endometrial stroma in normal endometrium and change of the immunoreactivity in dysfunctional uterine bleeding with evidence of 'disordered endometrial stroma'","volume":"40","author":"Mai","year":"2008","journal-title":"Pathology"},{"key":"10.1016\/j.ajog.2009.07.040_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-7292(00)90001-8","article-title":"FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers: FIGO committee on gynecologic oncology","volume":"70","author":"Benedet","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2009.07.040_bib26","first-page":"887","article-title":"Endometrial cancer: prevention, detection, management, and follow up","volume":"46","author":"Elit","year":"2000","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.ajog.2009.07.040_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2009.07.040_bib28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1528-1167.2006.00414.x","article-title":"Influence of lamotrigine and topiramate on MDR1 expression in difficult-to-treat temporal lobe epilepsy","volume":"47","author":"Wang-Tilz","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.ajog.2009.07.040_bib29","series-title":"Exploratory data analysis","author":"Tukey","year":"1977"},{"key":"10.1016\/j.ajog.2009.07.040_bib30","first-page":"1923","article-title":"R: a language for data analysis and graphics","volume":"5","author":"Inhaka","year":"1996","journal-title":"J Comput Graph Statist"},{"key":"10.1016\/j.ajog.2009.07.040_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol"},{"issue":"Suppl","key":"10.1016\/j.ajog.2009.07.040_bib32","first-page":"45","article-title":"Microvessel density assessment in benign and malignant endometrial changes","volume":"59","author":"Czekierdowski","year":"2008","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.ajog.2009.07.040_bib33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ygyno.2005.03.011","article-title":"Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study","volume":"97","author":"Sutton","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2009.07.040_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study","volume":"24","author":"Randall","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajog.2009.07.040_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ssu.2980100107","article-title":"FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina","volume":"10","author":"Kosary","year":"1994","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.ajog.2009.07.040_bib36","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer: a gynecologic oncology group study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2009.07.040_bib37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/1097-0142(19920101)69:1<200::AID-CNCR2820690132>3.0.CO;2-D","article-title":"The new International Federation of Gynecology and Obstetrics surgical staging and survival rates in early endometrial carcinoma","volume":"69","author":"Gal","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2009.07.040_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(02)02913-9","article-title":"Is there a difference in outcome between stage I-II endometrial cancer of papillary serous\/clear cell and endometrioid FIGO grade 3 cancer?","volume":"54","author":"Alektiar","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ajog.2009.07.040_bib39","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ygyno.2004.08.019","article-title":"Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium","volume":"95","author":"Creasman","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2009.07.040_bib40","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ygyno.2004.06.042","article-title":"High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy","volume":"95","author":"Mariani","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2009.07.040_bib41","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1200\/JCO.2005.01.112","article-title":"Clinical trial designs for predictive marker validation in cancer treatment trials","volume":"23","author":"Sargent","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajog.2009.07.040_bib42","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrc1946","article-title":"Predicting benefit from anti-angiogenic agents in malignancy","volume":"6","author":"Jubb","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajog.2009.07.040_bib43","first-page":"892","article-title":"Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma","volume":"7","author":"Kanamori","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajog.2009.07.040_bib44","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1086\/340026","article-title":"Protean PTEN: form and function","volume":"70","author":"Waite","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajog.2009.07.040_bib45","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncponc0403","article-title":"Lessons from phase III clinical trials on anti-VEGF therapy for cancer","volume":"3","author":"Jain","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.ajog.2009.07.040_bib46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1191\/1358863x06vm658ra","article-title":"Potential role of the Slit\/Robo signal pathway in angiogenesis","volume":"11","author":"Fujiwara","year":"2006","journal-title":"Vasc Med"},{"key":"10.1016\/j.ajog.2009.07.040_bib47","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1471-0528.1997.tb10979.x","article-title":"Recurrence of endometrial carcinoma and the value of routine follow up","volume":"104","author":"Salvesen","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2009.07.040_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4065\/83.1.97","article-title":"Current issues in the management of endometrial cancer","volume":"83","author":"Bakkum-Gamez","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ajog.2009.07.040_bib49","first-page":"389","article-title":"PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma","volume":"14","author":"Uegaki","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ajog.2009.07.040_bib50","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1210\/en.2006-1394","article-title":"Estrogen-induced activation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor expression, and edema in the uterus are mediated by the phosphatidylinositol 3-kinase\/Akt pathway","volume":"148","author":"Kazi","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajog.2009.07.040_bib51","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/jnci\/djn326","article-title":"Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design","volume":"100","author":"Pepe","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2009.07.040_bib52","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/nrc1550","article-title":"Bias as a threat to the validity of cancer molecular-marker research","volume":"5","author":"Ransohoff","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajog.2009.07.040_bib53","doi-asserted-by":"crossref","first-page":"14923","DOI":"10.1073\/pnas.0705310104","article-title":"Structural insights into the Slit-Robo complex","volume":"104","author":"Morlot","year":"2007","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937809008254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937809008254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:34:08Z","timestamp":1757586848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937809008254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0002937809008254"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2009.07.040","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased SLIT immunoreactivity as a biomarker for recurrence in endometrial carcinoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2009.07.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}